High group B streptococcus carriage rates in pregnant women in a tertiary institution in Nigeria

High group B streptococcus carriage rates in pregnant women in a tertiary institution in Nigeria

Charles John Elikwu^1,2,&, Oyinlola Oduyebo³, Folasade Tolulope Ogunsola³, Rose Ihuoma Anorlu⁴, Christy Nene Okoromah⁵, Brigitte König⁶

 

¹Department of Medical Microbiology & Parasitology, Ben Carson School of Medicine, Babcock University/Babcock University Teaching Hospitals, Ilisan-Remo, Ogun State, Nigeria, ²Department of Medical Microbiology & Parasitology, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria, ³Department of Medical Microbiology & Parasitology, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria, ⁴Department of Obstetrics & Gynaecology, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria, ⁵Department of Paediatrics and Child Health, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria, ⁶Institut für Medizinische Mikrobiologie und Infektionsepidemiologie, Universitätsklinikum Leipzig, Germany

 

 

^&Corresponding author
Charles John Elikwu, Department of Medical Microbiology & Parasitology, Babcock University Teaching Hospital, Ilisan-Remo, Ogun State, Nigeria

 

 

 

 

Group B ß-haemolytic streptococci were first recorded as a cause of human infection in 1938 [1]. Since then, several reports have shown that Group B Streptococcus (GBS) is responsible for a substantial proportion of invasive diseases including pneumonia, septicaemia and meningitis in new-borns [2-4] as well as neonatal sepsis, neonatal death, pyelonephritis and premature rupture of membranes [5]. While this bacterium causes diseases in children, women, immunocompromised adult and the elderly [6,7], serotype III strains have been significantly associated with meningitis in both early onset disease (EOD) and late onset disease (LOD) [8]. Since high genital inoculums at delivery, as detected by semi quantitative culture methods, significantly increase the likelihood of vertical transmission [9], infants, younger than 7 days, from heavily colonized women, are more likely to develop early-onset disease [10]. Its isolation from genital or lower gastrointestinal tracts of pregnant and non-pregnant women ranged from 5% to 40% [10]. However, when more than one appropriate site such as the lower vagina or the periurethral area or the rectum is sampled and selective broth media are utilized, the rate of colonization usually exceeds 20% [5,10]. These variations in the reported prevalence of asymptomatic colonization are due to differences in the sites sampled, bacteriologic method for detection of the organism, and demographic differences in the populations studied.

 

Though the prevalence of GBS in pregnant women and non-pregnant women as well as neonatal invasive diseases are rarely reported [11] and 21% of women in labour carry GBS in their rectum and/or vagina [12], 12-25.8% rates in Australia [13] and 35% rates have been recorded in the USA [14]. In the UK, up to 20% of women carry GBS in the vagina or rectum without any associated symptoms [15,16]. In the USA, it is the leading cause of neonatal disease since the 1970s [17-19]. In Nigeria, colonisation rates ranged from 6.6% to 20% [20-22]. Also, the perinatal mortality rates (PNMRs) of about 86 per 1000, one of the highest in the world, live births in the year 2000 [23] and PNMR of 78 per 1000 live births [24] have been indicated. This is in comparison to the perinatal mortality rate of 50 per 1000 live births in other developing regions of the world and 10 per 1000 live births in more industrialized countries. Consequently, while reducing childhood mortality levels by two-thirds by the year 2015 became one of the Millennium Development Goals (MDG-4) set by the United Nations [25] to substantially reduce perinatal deaths in high mortality countries [23,26], perinatal mortality rate (PNMR) resulting from GBS infections has, also, become one of the key indicators of ill health [27]. Since there has been mounting reports that GBS is an important cause of neonatal sepsis in various parts of sub-Saharan Africa for over a decade [28-30], it is, therefore, pertinent to investigate the role of GBS in neonatal disease in Nigeria. This study was, therefore, designed to determine the vagino-rectal carriage of GBS colonization in pregnant women, to compare rates of microbial detection between specimen culturing and polymerase chain reactions (PCR) and to identify risk factors associated with GBS colonization as well as distribution of serotypes among isolates from pregnant women and their newborns.

 

 

Study area and population: participants for this study were recruited from the antenatal clinic of the Lagos University Teaching Hospital, (LUTH) a 761-bed tertiary care facility located in Surulere, Lagos, South-West Nigeria. Molecular studies were done at the Institut für Medizinische Mikrobiologie und Infektionsepidemiologie, Universitätsklinikum, Leipzig, Germany.

 

Study design/population: this was a cross-sectional study conducted between December 2010 and October 2011 at the Lagos University Teaching Hospital. The study recruited pregnant women at gestational age of = 28 weeks, attending the antenatal clinic of LUTH and those who presented in labour at the delivery wards. Participants were investigated for GBS carriage rates and most common serotypes. The newborns of colonized mothers were also included in the study.

 

Inclusion criteria/exclusion criteria: all consenting pregnant women with gestation age = 28 weeks, parturient women and their newborns were recruited into the study. Women below 28 weeks gestation and who had received antibiotics within two weeks of presenting at the antenatal clinic were excluded from the study.

 

Sample size determination: the minimum sample size was determined by the formula [31]: N = Z² pq/d², where, N = Sample size; P = 0.2 (based on Prevalence rate of 20% reported in previous local study; q = 1-p; Z = 1.96 (critical value at 95% confidence level); d = Precision, usually 5%; N = (1.96)² (0.2)(0.8)/(0.05) ² = 244. A sample size of 300 was used to increase the validity of the study with an expectation that not more than 20% of participants would be excluded in data analysis due to improperly filled questionnaire or refusal to respond to questions.

 

Sampling technique: the fact that universal screening for GBS among pregnant women has not yet been adopted as a policy in our environment and that potential participants were at different gestational age at presentation, convenience sampling was employed to choose participants from the population of pregnant women who presented for antenatal care and labor.

 

Ethics statement: the study protocol was approved by the institutional review board of Lagos University Teaching Hospital, Lagos, Nigeria (IRB No. ADM/DCST/221). Informed consent was confirmed by the IRB.

 

Specimen collection: a set of vagino-rectal swab samples consisting of two swabs were taken. Each swab was first inserted into the vagina and then the rectum. The first swab was the regular sterile cotton swab taken from each of the 300 pregnant women. The second was eSwabs (Copan Diagnostics, USA) collected from only 175 of the pregnant women. In addition, sterile cotton swabs from the mouth, ear and umbilical stump were taken from newborns included in the study. The regular sterile cotton swab did not have transport media but the eSwabs did. The cotton swabs and eSwabs were refrigerated in the clinic and immediately transported to the laboratory on ice packs for analysis on the day of collection. Vaginal swabs were transferred direct to the laboratory within 5 minutes of collecting samples from the antenatal clinic.

 

Storage and transport of GBS Isolates and eSwab samples: all GBS isolates from mothers and babies were stored in 20% glycerol broth (Brain Heart infusion containing 20% pure glycerol) and peptone water for freezing of organism in -80oC for molecular studies. The eSwab samples (eSwab 480CE, LQ Amies, Copan Diagnostics, USA) were stored at -20°C and were later transported in line with standard practice to the Institutfür Medizinische Mikrobiologie, und Infektions epidemiologie, Universitat sklinikum, Leipzig, Germany, for PCR studies.

 

Analysis of specimen

 

Microbiology: cotton swab samples from pregnant mothers and neonates were inoculated into Todd Hewitt broth supplemented with 15 µg/ml nalidixic acid and 10 µg/ml colistin (Biomerieux, Germany) subcultured on Columbia agar to which 5% sheep blood has been added (Oxoid, United Kingdom) and on freshly prepared CHROMagar™ StrepB(CHROMagar, France) before being incubated at 37°C in ambient air for 24-48 h. The colonies on the solid media were presumptively identified as Group B Streptococcus if they were Gram-positive cocci, catalase-negative, and positive to CAMP test [32] as well as forming small mauve to pink colonies on CHROMagarStrepB.

 

DNA extractions: total DNA extraction from overnight GBS isolates and eSwabs suspensions was carried out using the DNeasy Blood & Tissue Kits (Qiagen, Germany) according to the manufacturer´sinstructions.

 

PCR assays: confirmatory conventional PCR, a multiplex PCR assay for the identification of capsular serotype genes and a conventional PCR to discern the gbs2018-ST-17 gene (specific for sequence type(ST)-17 clone) were performed on all GBS isolates from mothers and newborns as previously described [33-35]. Direct PCR was performed on eSwabs samples to detect GBS using GBS-specific primers as previously described [35]. Strict precautions to prevent carryover of amplified DNA were applied as previously described [36].

 

Statistical analysis: data entry and analysis were done using Epi-Info software, version 3.5.1. August 2008. Frequency tables, charts and cross-tables were used to present the data. The Chi-square test and Fisher’s exact test were used to compare the two groups, while the difference in means between groups was assessed using student’s t-test. p values < 0.05 were considered statistically significant.

 

 

Socio-demographic characteristics: a total of 300 pregnant women and 53 neonates were enrolled in the study. For logistics reasons, only 175 eSwabs from mothers were studied by PCR. The mean age of the participants was 30.95 ± 4.36 years (SD) (range 18-45 years). Table 1 shows socio-demographic characteristics of the women. The frequency of intercourse was 1 to 7 times a week with a mean of 1.73 and SD of 0.95.

 

GBS isolation and detection: fifty-nine (19.7%) out of 300 women studied by culture showed GBS-vaginal colonization, while 112 (64%) of 175 mothers (eSwab) investigated by PCR were colonized. The gene sequencing done on the randomly selected eSwab PCR products yielded a 97% match with the CAMP factor (cfb) gene sequence of Streptococcus agalactiae strain GDzl (accession number: GU217532.1). GBS was isolated from four (6.8%) neonates born to mothers with GBS-vaginal colonization and from seven (13.21%) neonates born to mothers in whom GBS was not cultured from vaginal swabs. All isolates were confirmed GBS by a conventional PCR.

 

Serotype distribution/ ST-17 clone among GBS Isolates: of the 59 vagino-rectal colonizing isolates, only 46 (78%) as well as seven of 11 colonizing strains in the newborns were available for molecular capsular typing and gbs2018-ST-17 gene determination. Figure 1 shows the characteristic bands pattern of the GBS serotypes distribution on agarose gel. CPS type Ia was the most common of the colonising strains in mothers (23.9%, n=11, Figure 2) while CPS type II was the most common GBS strain in newborns (n=5). Only one CPS type III occurred among colonising strains in the newborns. Four of the seven colonizing isolates in newborns, and 12 vagino-rectal colonizing isolates, were of the ST-17 lineage or clone. Among colonizing strains in newborns, this clone comprised of two strains of serotype II and one strain each of serotype Ia and III as shown in Figure 3.

 

Risk factors for GBS colonization/Infection: the association between risk factors and colonization of the maternal vagino-rectal region by GBS is summarized in Table 2 indicating a frequency of intercourse ≥ two times per week as a risk factor for GBS colonization.

 

 

In this study the rate obtained by culture only was much lower than the rate obtained by PCR, but falls in the range of carriage rates (6.6% to 20%) reported from previous studies in pregnant Nigerian women [30,37-39]. The wide disparities between culture and PCR results could be attributed to the presence of nonviable GBS in the vaginal swabs or low bacterial load that could not be detected by culture but who’s DNA would be present for PCR amplification [40,41]. Also, GBS detection by culture could also be inhibited by antibiotics and feminine hygiene products [40]. Using a culture method alone, some pregnant women colonized by GBS might be missed, especially in Nigeria where there are high rates of antibiotic misuse and abuse [42]. Despite the high colonisation rate in the present study, the low mother-to-baby transmission rate (6.8%) based on culture results in mothers during labour was much lower than the 28% transmission rate obtained from a similar study in the hospital in 1988 [43]. This may be due to widespread and discriminate use of penicillin to which GBS is still susceptible [42]. Also, it is a common obstetrics practice in Nigeria to wipe the vulva with antiseptic lotion during repetitive vagina examination during labour. This may be the reason why the high maternal carriage of GBS in this study did not translate to a correspondingly high rate of transmission to the newborns. In addition, none of the colonised babies developed invasive disease. This finding confirmed earlier observations that GBS is not a common cause of neonatal infection in Nigeria [30,37,43]. In recent times, studies from Kenya [23], South Africa [26,29], Zimbabwe [27,44] and Malawi [45] suggest that GBS is an important cause of neonatal sepsis in Africa, a study from south-eastern part of Nigeria reported a case of GBS neonatal sepsis from 33 septicaemic neonates screened [46].

 

In contrast to the study conducted in this hospital in 1988 in which the predominant strain isolated was serotype III (20/36; 55%) from both mothers and babies [43], this study showed that there are a variety of colonising serotypes and they are similar to serotypes circulating globally. Here, serotypes Ia and III were the predominant serotypes found in mothers (44.7%) in contrast to predominantly serotype II found in the babies (71.4%). These contrasting pictures suggested, perhaps, there has been a shift in circulating GBS serotypes. This range of serotypes distribution is similar to those found across the African subcontinent, though the most common serotypes may differ from country to country [28,44,45]. Also, GBS serotype II-ST-17 strains were rarely associated with invasive disease in neonates unlike their serotype III-ST-17 counterparts. This could be attributed to the fact that relative to serotype III strains, other serotypes showed reduced invasive potential [34,47,48]. In this study, there was a significant association between coital frequency of twice a week or more and GBS carriage (X² = 2.2; p value < 0.05). This finding raises a number of questions. Is GBS sexually transmitted? Is there an association between GBS vaginal colonization and an elevated pH in the vaginal environment? However, a number of literature had reported this association [49-54]. Although, other predisposing factors such as preterm delivery, prolonged rupture of membrane and intra-amniotic infection [55,56] that increases the baby’s risk of a GBS colonisation and infection were absent in all mothers studied, three women with positive GBS carriage had intrapartum fever.Prevention strategies ofGBS neonatal infection by identifying and prophylactically treating pregnant women, avoiding postpartum problems and early neonatal infections [56,57] would be a worthy intervention.

 

 

This study showed that GBS carriage in the studied population was high and transmission rate was low and indicated low rates of association between the serotypes and the diseases. Of significance, the study suggested a changing epidemiology of GBS which therefore requires regular surveillance for early detection of the introduction of more virulent strains that may signal the potential for invasive GBS disease among our neonates. Though, none of the babies studied had invasive GBS disease, a more expansive study in the future will be required to validate how uncommon the invasiveness of GBS neonatal disease is in Nigeria while prenatal screening of pregnant women at 35-37 weeks of gestation should be in view as efforts are being made towards the implementation of institutional and national antibiotic stewardship.

 

 

The authors declared no competing interest.

 

 

Conception and design: CJE, OOO, FTO, BK. Acquisition of data: CJE, BK. Analysis and interpretation of data: CJE, OOO, FTO, BK. Contributed reagents/materials: CJE, BK. Writing/revision of manuscript: CJE, OOO, FTO, RIA, CAO. Study supervision: OOO, FTO, BK.

 

 

Deutscher Akademischer Austausch Dienst (DAAD; German Academic Exchange Program) for providing a short term research grant to analyze the samples in Institut für Medizinische Mikrobiologie und Infektionsepidemiologie, Universitätsklinikum Leipzig, Germany. CHROMagar (France) for providing the CHROMagarStrepB agar. Dr. Lesley McGee of the CDC for providing Streptococcus agalactiae serotypes, haemolysin-producing Staphylococcus aureus reference strains and primers used in the multiplex PCR assay for this study. The Medical staff of the Obstetrics/Gynaecology and Paediatrics Departments of LUTH who assisted with the sample collections. Bryan Nyary assisted with the proofreading of this manuscript.

 

 

Table 1: socio-demographic characteristics and GBS status of Respondents

Table 2: association of age, parity and coital frequency with GBS carriage

Figure 1: gel electrophoresis identification of GBS capsular serotypes (cps) genes. Lane 1(serotype Ia reference strain); Lane 2 (serotype Ib reference strain); Lane 3 (serotype II reference strain); Lane 4 (serotype III reference strain); Lane5 (serotype IV reference strain); Lane 6 (serotype V reference strain); Lane 7 (serotype serotype VI reference strain); Lane 8 (serotype VII reference strain); Lane 9 (serotype VIII reference strain); Lane 10 (serotype Ia isolate); Lane 11 (serotype V isolate); Lane 12 (serotype III isolate); Lanes ML/MM (100bp molecular ladders)

Figure 2: ST- 17 distributions among maternal GBS Serotypes

Figure 3: ST- 17 distributions among neonatal GBS Serotypes

 

 

1. Fry RM. Fatal Infections by HemolyticStreptococcus Group B. The Lancet. 1938; 231(5969):199-201. PubMed | Google Scholar


2. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype Distribution and Invasive Potential of Group B Streptococcus Isolates Causing Disease in Infants and Colonizing Maternal-Newborn Dyads. PLoS ONE. 2011; 6(3):e17861. PubMed | Google Scholar


3. Bohnsack JF, Whiting A, Gottschalk M, Dunn DM, Weiss R, Azimi PH, Philips JB, III, Weisman LE, Rhoads GG, Lin FYC. Population Structure of Invasive and Colonizing Strains of Streptococcus agalactiae from Neonates of Six U.S. Academic Centers from 1995 to 1999. Journal of Clinical Microbiology. 2008; 46(4):1285-1291. PubMed | Google Scholar


4. Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, Orefici G, Dicuonzo G, Creti R. Molecular Epidemiology and Distribution of Serotypes, Surface Proteins, and Antibiotic Resistance among Group B Streptococci in Italy. Journal of Clinical Microbiology. 2007; 45(9):2909-2916. PubMed | Google Scholar


5. Cagno CK, Pettit JM, Weiss BD. Prevention of perinatal group B streptococcal disease: Updated CDC guideline. Am Fam Physician. 2012; 86(1):59–65. PubMed | Google Scholar


6. Amaya RA, Baker CJ, Keitel WA, Edwards MS. Healthy Elderly People Lack Neutrophil-Mediated Functional Activity to Type V Group B Streptococcus. Journal of the American Geriatrics Society. 2004; 52(1):46-50. PubMed | Google Scholar


7. Palazzi DL, Rench MA, Edwards MS, Baker CJ. Use of type V group B streptococcal infections in infants. J Pediatr. 2004; 95:437-443. PubMed | Google Scholar


8. Poyart C, Tazi A, Réglier-Poupet H, Billoët A, Tavares N, Raymond J, Trieu-Cuot P. Multiplex PCR Assay for Rapid and Accurate Capsular Typing of Group B Streptococci. Journal of Clinical Microbiology. 2007; 45(6):1985-1988. PubMed | Google Scholar


9. Ancona RJ, Ferrieri P, Williams PP. Maternal factors that enhance the acquisition of group-B streptococci by newborn infants. Journal of Medical Microbiology. 1980; 13(2):273-280. PubMed | Google Scholar


10. Regan JA, Klebanoff MA, Nugent RP, Eschenbach D, Blackwelder W, Lou Y et al. Colonization with group B streptococci in pregnancy and adverse outcome. American Journal of Obstetrics and Gynecology. 1996; 174(4):1354-1360. PubMed | Google Scholar


11. World Health Organization Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The Pediatric Infectious Disease Journal. 1999; 18(Supplement):S17-S22. PubMed | Google Scholar


12. Daniels JP, Gray J, Pattison HM, Gray R, Hills R, Khan K. Intrapartum tests for group B streptococcus: accuracy and acceptability of screening. BJOG: An International Journal of Obstetrics & Gynaecology. 2010; 118(2):257-265. PubMed | Google Scholar


13. Garland SM, Kelly N, Ugoni AM. Early-onset neonatal group B streptococcal sepsis: economic of various prevention strategies. Med J Australia. 2002; 162:413-417. PubMed | Google Scholar


14. Molnar P. Can pregnant women obtain their own specimens for group B streptococcus? A comparison of maternal versus physician screening. The Mount Sinai GBS Screening Group. Family Practice. 1997; 14(5):403-406. PubMed | Google Scholar


15. Hassain IA, Onon TS, Weston D, Isalska B, Wall K, Afshar B, et al. A quantitative descriptive study of the prevalence of carriage (colonisation) of haemolytic streptococci groups A, B, C and G in pregnancy. Journal of Obstetrics & Gynaecology. 2011; 31(3):207-209. PubMed | Google Scholar


16. Kandi V. Group B streptococcal carriage among pregnant women and its implications. Int J ReprodContraceptObstet Gynecol. 2015; 4(2):301-304. PubMed | Google Scholar


17. CDC. Diminishing Racial Disparities in Early-Onset Neonatal Group B Streptococcal Disease - United States, 2000-2003. JAMA. 2004; 292(6):676-677. PubMed | Google Scholar


18. Dermer P, Lee CH, Eggert J, Few B. A history of neonatal group B streptococcus with its related morbidity and mortality rates in the United States. Journal of Pediatric Nursing. 2004; 19(5):357-363. PubMed | Google Scholar


19. Mullaney DM. Group B streptococcal infections in newborns. J ObstetGynecol Neonatal Nurs. 2001; 30:649-658. PubMed | Google Scholar


20. Nsagha DS, Bello CSS, Kahdakai-Olutemi VT. Maternal carriage in pregnancy of Group B streptococcus in Jos: Relation of Endo Cervical and Anorectal colonization. NigQt J Hosp Med. 1997; 7:53-56. PubMed | Google Scholar


21. Uhiara JE. Group B streptococcal carriage among parturient and their neonates in Zaria, Nigeria. Afr J Med Med Sci. 1993; 22:79-83. PubMed | Google Scholar


22. Onile BA. Group B Streptococcus carriage in Nigeria. Tran Roy Soc Trop Med &Hyg. 1990; 74:367-370. PubMed | Google Scholar


23. World Health Organization W. Neonatal and perinatal mortality: country, regional and global estimates. Geneva: World Health Organization [Internet]. 2006 [cited 15 October 2015]; Available from: http://www.who.int/iris/handle/10665/43444#sthash.GVYWZpEe.dpuf. PubMed | Google Scholar


24. Ekure EN, Ezeaka VC, Iroha EO, Egri-Okwaji MT. Neonatal Mortality of In-borns in the Neonatal Unit of a Tertiary Centre in Lagos, Nigeria. Nig Quart J Hosp Med. 2008; 15(2):55-58. PubMed | Google Scholar


25. Seale A, Mwaniki M, Newton C, Berkley J. Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. The Lancet Infectious Diseases. 2009; 9(7):428-438. PubMed | Google Scholar


26. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: When? Where? Why?. The Lancet. 2005; 365(9462):891-900. PubMed | Google Scholar


27. Wilkinson D. Reducing Perinatal Mortality in Developing Countries. Health Policy and Planning. 1997; 12(2):161-165. PubMed | Google Scholar


28. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S. Bacteremia among Children Admitted to a Rural Hospital in Kenya. N Engl J Med. 2005; 352(1):39-47. PubMed | Google Scholar


29. Madhi SA, Radebe K, Crewe-Brown H, Frasch CE, Arakere G, Mokhachane M et al. High burden of invasive Streptococcus agalactiae disease in South African infants. Annals of Tropical Paediatrics. 2003; 23(1):15-23. PubMed | Google Scholar


30. Nathoo KJ, Mason PR, Chimbira TH. Neonatal septicaemia in Harare Hospital: etiology and risk factors, the Puerperal Sepsis Study Group. Cent Afr J Med. 1990; 36:150-156. PubMed | Google Scholar


31. Cochran WG. Sampling Techniques. New York: John Wiley and Sons, Inc.1963; 2nd Ed. PubMed | Google Scholar


32. Hansen SM, Sorensen UB. Method for Quantitative Detection and Presumptive Identification of Group B Streptococci on Primary Plating. Journal of Clinical Microbiology. 2003; 41(4):1399-1403. PubMed | Google Scholar


33. Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. Journal of Microbiological Methods. 2010; 80(2):212-214. PubMed | Google Scholar


34. Lamy MC, Dramsi S, Billoet A, Reglier-Poupet H, Tazi A, Raymond J, Guerin F, Couve E, Kunst F, Glser P, Trieu-Cuot P, Poyart C. Rapid detection of the “highly virulent” group B Streptococcus ST-17 clone. Microbes Infect. 2006; 8:1714–22. PubMed | Google Scholar


35. Ke D, Menard C, Picard FJ, Boissinot M, Ouellette M, Roy P H, Bergeron MG. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem. 2000; 46(1):324-33. PubMed | Google Scholar


36. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989; 339(6221):237-238. PubMed | Google Scholar


37. Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT. Characterization of Group B Streptococci Recovered from Infants with Invasive Disease in England and Wales. Clinical Infectious Diseases. 2004; 38(9):1203-1208. PubMed | Google Scholar


38. Shet A, Ferrieri P. Neonatal & maternal group B streptococcal infections: a comprehensive review. Indian J Med Res. 2004; 120:141–150. PubMed | Google Scholar


39. Schrag SJ, Schuchat A. Easing the Burden: Characterizing the Disease Burden of Neonatal Group B Streptococcal Disease to Motivate Prevention. Clinical Infectious Diseases. 2004; 38(9):1209-1211. PubMed | Google Scholar


40. AtkinsKL, Atkinson RM, Shanks A, Parvinn CA, Dunne WM, Gross G. Evaluation of Polymerase Chain Reaction for Group B Streptococcus Detection Using an Improved Culture Method. Obstetrics & Gynecology. 2006; 108(3, Part 1):488-491. PubMed | Google Scholar


41. Ostroff RM, Steaffens JW. Effect of specimen storage, antibiotics, and feminine hygiene products on the detection of Group B Streptococcus by culture and the STREP B OIA test. Diagnostic Microbiology and Infectious Disease. 1995; 22(3):253-259. PubMed | Google Scholar


42. Arikpo GE, Eja ME, Enyi-Idoh KH, Akubuenyi F, Ngang U, Akam C, Ekomabasi I. Patterns of antibiotic drug use in southern Nigeria communities. World J ApplSci Technol. 2011; 3(1):86-89. PubMed | Google Scholar


43. Banjo TO, Rotimi VO, Abudu OO. Colonization of pregnant mothers and their babies by group B Streptococci. West Afr J Med. 1988;7:91-96. PubMed | Google Scholar


44. Moyo SR, Maeland JA, Bergh K. Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe. Journal of Medical Microbiology. 2002; 51(7):595-662. PubMed | Google Scholar


45. Milledge J, Calis JC, Graham SM, Phiri A, Wilson LK, Soko D. Aetiology of neonatal sepsis in Blantyre, Malawi: 1996–2001. Ann Trop Paediatr. 2005; 25:101–110. PubMed | Google Scholar


46. Ojukwu JU, Abonyi LE, Ugwu J, Orji IK. Neonatal septicemia in high risk babies in South-Eastern Nigeria. J Perinat Med. 2006; 34(2):166-172. PubMed | Google Scholar


47. Lin FY, Whiting A, Adderson E, Takahashi S, Dunn DM, Weiss R et al. Phylogenetic Lineages of Invasive and Colonizing Strains of Serotype III Group B Streptococci from Neonates: a Multicenter Prospective Study. Journal of Clinical Microbiology. 2006; 44(4):1257-1261. PubMed | Google Scholar


48. Davies HD, Jones N, Whittam TS, Elsayed S, Bisharat N, Baker CJ. Multilocus Sequence Typing of Serotype III Group B Streptococcus and Correlation with Pathogenic Potential. The Journal of Infectious Diseases. 2004; 189(6):1097-1102. PubMed | Google Scholar


49. Foxman B, Gillespie BW, Manning SD, Marrs CF. Risk Factors for Group B Streptococcal Colonization: Potential for Different Transmission Systems by Capsular Type. Annals of Epidemiology. 2007; 17(11):854-862. PubMed | Google Scholar


50. Manning SD, Neighbors K, Tallman PA, Gillespie B, Marrs C, Borchardt S et al. Prevalence of Group B Streptococcus Colonization and Potential for Transmission by Casual Contact in Healthy Young Men and Women. Clinical Infectious Diseases. 2004; 39(3):380-388. PubMed | Google Scholar


51. Meyn LA, Moore DM, Hillier SL, Krohn MA. Association of Sexual Activity with Colonization and Vaginal Acquisition of Group B Streptococcus in Nonpregnant Women. American Journal of Epidemiology. 2002; 155(10):949-957. PubMed | Google Scholar


52. Bliss SJ, Manning SD, Tallman P, Baker C, Pearlman M, Marrs C et al. Group B Streptococcus Colonization in Male and Nonpregnant Female University Students: A Cross Sectional Prevalence Study. Clinical Infectious Diseases. 2002; 34(2):184-190. PubMed | Google Scholar


53. Yamamoto T, Nagasawa I, Nojima M, Yoshida K, Kuwabara Y. Sexual Transmission and Reinfection of Group B Streptococci between Spouses. Journal of Obstetrics and Gynaecology Research. 1999; 25(3):215-219. PubMed | Google Scholar


54. Newton ER, Butler MC, Shain RN. Sexual Behavior and Vaginal Colonization by Group B Streptococcus among Minority Women. Obstetrics & Gynecology. 1996; 88(4):577-582. PubMed | Google Scholar


55. Adair CE, Kowalsky L, Quon H. Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study. CMAJ. 2003; 169(3):198-203. PubMed | Google Scholar


56. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS et al. A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates. N Engl J Med. 2002; 347(4):233-239. PubMed | Google Scholar


57. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986; 314:1665-1669. PubMed | Google Scholar